Impact of anticancer drugs price cut on physician’s prescription choices on first-line chemotherapy regimens and health expenditure for advanced non-small cell lung cancer in China

Journal of Thoracic Disease

Yan-Qing Zheng²  Luan-Luan Sun¹  Mei-Ying Li²  Jian Wang²  Bei Li²  Jing Hao² 

[1] Nuffield Department of Population Health, University of Oxford, Oxford, UKNuffield Department of Population Health, University of Oxford, Oxford, UKNuffield Department of Population Health, University of Oxford, Oxford, UK;Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan 250012, ChinaDepartment of Medical Oncology, Qilu Hospital of Shandong University, Jinan 250012, ChinaDepartment of Medical Oncology, Qilu Hospital of Shandong University, Jinan 250012, China

关键词: Anticancer drugs price cut;    physician’s prescription choices;    advanced non-small cell lung cancer;    China;   

DOI  :  10.21037/jtd.2016.09.35

学科分类：呼吸医学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown